+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)
Amgen Inc. - logo

Amgen is an international biotechnology company based in California, USA. Amgen is committed to using their experience in human genetics and biologics manufacturing to create innovative treatments for life threatening diseases particularly in areas of unmet medical need where limited treatment options exist. Amgen manufactures a wide range of therapeutic products including Aranesp, Corlanor, Neulasta and Prolia.

Gene Delivery Systems - Global Strategic Business Report - Product Thumbnail Image

Gene Delivery Systems - Global Strategic Business Report

  • Report
  • November 2025
  • 196 Pages
  • Global
From
Pharma R&D Outsourcing Market - Global Outlook & Forecast 2022-2027 - Product Thumbnail Image

Pharma R&D Outsourcing Market - Global Outlook & Forecast 2022-2027

  • Report
  • September 2022
  • 357 Pages
  • Global
From
Pharmaceutical Market in Denmark 2025-2029 - Product Thumbnail Image

Pharmaceutical Market in Denmark 2025-2029

  • Report
  • March 2025
  • 186 Pages
  • Denmark
From
Female Contraceptive Market 2024-2028 - Product Thumbnail Image

Female Contraceptive Market 2024-2028

  • Report
  • May 2024
  • 178 Pages
  • Global
From
Drug Repurposing - Global Strategic Business Report - Product Thumbnail Image

Drug Repurposing - Global Strategic Business Report

  • Report
  • November 2025
  • 377 Pages
  • Global
From
From
Recombinant Proteins - Global Strategic Business Report - Product Thumbnail Image

Recombinant Proteins - Global Strategic Business Report

  • Report
  • November 2025
  • 214 Pages
  • Global
From
Melanoma Treatment Market - Forecasts from 2022 to 2027 - Product Thumbnail Image

Melanoma Treatment Market - Forecasts from 2022 to 2027

  • Report
  • May 2022
  • 120 Pages
  • Global
From
Metastatic Cancer Drugs - Global Strategic Business Report - Product Thumbnail Image

Metastatic Cancer Drugs - Global Strategic Business Report

  • Report
  • November 2025
  • 377 Pages
  • Global
From
Nasopharyngeal Cancer Treatment - Global Strategic Business Report - Product Thumbnail Image

Nasopharyngeal Cancer Treatment - Global Strategic Business Report

  • Report
  • November 2025
  • 288 Pages
  • Global
From
Combination Antibody Therapy - Global Strategic Business Report - Product Thumbnail Image

Combination Antibody Therapy - Global Strategic Business Report

  • Report
  • November 2025
  • 196 Pages
  • Global
From
Cancer Immunotherapy - Global Strategic Business Report - Product Thumbnail Image

Cancer Immunotherapy - Global Strategic Business Report

  • Report
  • November 2025
  • 291 Pages
  • Global
From
Sarcoma Drugs - Global Strategic Business Report - Product Thumbnail Image

Sarcoma Drugs - Global Strategic Business Report

  • Report
  • November 2025
  • 126 Pages
  • Global
From
Chemotherapy Treatment - Global Strategic Business Report - Product Thumbnail Image

Chemotherapy Treatment - Global Strategic Business Report

  • Report
  • November 2025
  • 188 Pages
  • Global
From
From
Metastatic Bone Disease - Global Strategic Business Report - Product Thumbnail Image

Metastatic Bone Disease - Global Strategic Business Report

  • Report
  • November 2025
  • 194 Pages
  • Global
From
Hedgehog Pathway Inhibitors - Global Strategic Business Report - Product Thumbnail Image

Hedgehog Pathway Inhibitors - Global Strategic Business Report

  • Report
  • November 2025
  • 102 Pages
  • Global
From
Ewing Sarcoma - Global Strategic Business Report - Product Thumbnail Image

Ewing Sarcoma - Global Strategic Business Report

  • Report
  • November 2025
  • 377 Pages
  • Global
From
From
Loading Indicator